NLSP NLS Pharmaceutics
- 0.2018
- +0.0018+0.90%
- 0.2015
- -0.0003-0.15%
NLS Pharmaceutics News
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
F-1: Registration statement for securities of certain foreign private issuers
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
NT 20-F: Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
NLS Pharmaceutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
NLS Pharmaceutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
NLS Pharmaceutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
NLS Pharmaceutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
NLS Pharmaceutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
NLS Pharmaceutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
NLS Pharmaceutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
NLS Pharmaceutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
NLS Pharmaceutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Analysis
Price Target
No Data
